Douglas B. Muchmore

2.6k total citations · 1 hit paper
56 papers, 1.9k citations indexed

About

Douglas B. Muchmore is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Douglas B. Muchmore has authored 56 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Endocrinology, Diabetes and Metabolism, 21 papers in Surgery and 15 papers in Genetics. Recurrent topics in Douglas B. Muchmore's work include Diabetes Management and Research (33 papers), Pancreatic function and diabetes (21 papers) and Inhalation and Respiratory Drug Delivery (13 papers). Douglas B. Muchmore is often cited by papers focused on Diabetes Management and Research (33 papers), Pancreatic function and diabetes (21 papers) and Inhalation and Respiratory Drug Delivery (13 papers). Douglas B. Muchmore collaborates with scholars based in United States, United Kingdom and Germany. Douglas B. Muchmore's co-authors include Daniel E. Vaughn, Lutz Heinemann, Julio Rosenstock, Amparo de la Peña, Michael Miller, Henry Schmitt, Monica Morrow, Avraham Karasik, David W Purdie and J Štěpán and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Douglas B. Muchmore

56 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Continued Breast Cancer Risk Reduction in Postmenopausal Women Treated with Raloxifene: 4-Year Results from the MORE Trial

2001 505 citations Douglas B. Muchmore et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Douglas B. Muchmore United States	22	793	732	460	407	350	56	1.9k
Nina H. Bjarnason Denmark	11	748 0.9×	1.1k 1.5×	785 1.7×	619 1.5×	184 0.5×	18	2.2k
Kristin K. Deeb United States	12	192 0.2×	352 0.5×	362 0.8×	546 1.3×	103 0.3×	29	1.8k
A. O. Mueck Germany	24	530 0.7×	781 1.1×	297 0.6×	316 0.8×	72 0.2×	80	1.5k
B. Vandewalle France	32	733 0.9×	918 1.3×	335 0.7×	910 2.2×	1.2k 3.4×	89	2.7k
Noboru Kubodera Japan	25	231 0.3×	463 0.6×	407 0.9×	584 1.4×	108 0.3×	107	2.3k
Dieter M. Kramsch United States	18	396 0.5×	178 0.2×	87 0.2×	317 0.8×	739 2.1×	43	2.1k
Yuri Yamaguchi Japan	22	166 0.2×	679 0.9×	534 1.2×	778 1.9×	138 0.4×	52	1.9k
Paolo Filipponi Italy	25	314 0.4×	119 0.2×	441 1.0×	459 1.1×	278 0.8×	85	1.6k
Ruth A. Henderson United States	12	153 0.2×	690 0.9×	242 0.5×	329 0.8×	73 0.2×	15	1.4k
Hiromu Nakajima Japan	28	583 0.7×	580 0.8×	69 0.1×	682 1.7×	806 2.3×	84	2.1k

Countries citing papers authored by Douglas B. Muchmore

Since Specialization

Citations

This map shows the geographic impact of Douglas B. Muchmore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas B. Muchmore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas B. Muchmore more than expected).

Fields of papers citing papers by Douglas B. Muchmore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas B. Muchmore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas B. Muchmore. The network helps show where Douglas B. Muchmore may publish in the future.

Co-authorship network of co-authors of Douglas B. Muchmore

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas B. Muchmore. A scholar is included among the top collaborators of Douglas B. Muchmore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas B. Muchmore. Douglas B. Muchmore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Huang, Jingtong, Guillermo Arreaza-Rubín, Barry H. Ginsberg, et al.. (2023). NIH Fifth Artificial Pancreas Workshop 2023: Meeting Report: The Fifth Artificial Pancreas Workshop: Enabling Fully Automation, Access, and Adoption. Journal of Diabetes Science and Technology. 18(1). 215–239. 7 indexed citations

Bailey, Timothy S., et al.. (2022). Progressive Acceleration of Insulin Exposure Over 7 Days of Infusion Set Wear. Diabetes Technology & Therapeutics. 25(2). 143–147. 1 indexed citations

Brown, Samuel M., Douglas B. Muchmore, Elif I. Ekinci, et al.. (2022). Feasibility study of a prototype extended‐wear insulin infusion set in adults with type 1 diabetes. Diabetes Obesity and Metabolism. 24(6). 1143–1149. 7 indexed citations

Klonoff, David C., et al.. (2019). Divergent Hypoglycemic Effects of Hepatic-Directed Prandial Insulin: A 6-Month Phase 2b Study in Type 1 Diabetes. Diabetes Care. 42(11). 2154–2157. 19 indexed citations

Rosengren, Sanna, Samuel S. Dychter, Marie A. Printz, et al.. (2015). Clinical Immunogenicity of rHuPH20, a Hyaluronidase Enabling Subcutaneous Drug Administration. The AAPS Journal. 17(5). 1144–1156. 44 indexed citations

Garg, Satish K., John B. Buse, Jay S. Skyler, Daniel E. Vaughn, & Douglas B. Muchmore. (2014). Subcutaneous injection of hyaluronidase with recombinant human insulin compared with insulin lispro in type 1 diabetes. Diabetes Obesity and Metabolism. 16(11). 1065–1069. 9 indexed citations

Morrow, Linda, Douglas B. Muchmore, Elizabeth Ludington, Daniel E. Vaughn, & Marcus Hompesch. (2011). Reduction in Intrasubject Variability in the Pharmacokinetic Response to Insulin After Subcutaneous Co-Administration with Recombinant Human Hyaluronidase in Healthy Volunteers. Diabetes Technology & Therapeutics. 13(10). 1039–1045. 14 indexed citations

Muchmore, Douglas B. & Daniel E. Vaughn. (2010). Review of the Mechanism of Action and Clinical Efficacy of Recombinant Human Hyaluronidase Coadministration with Current Prandial Insulin Formulations. Journal of Diabetes Science and Technology. 4(2). 419–428. 37 indexed citations

Vaughn, Daniel E., Richard C. Yocum, Douglas B. Muchmore, et al.. (2009). Accelerated Pharmacokinetics and Glucodynamics of Prandial Insulins Injected With Recombinant Human Hyaluronidase. Diabetes Technology & Therapeutics. 11(6). 345–352. 41 indexed citations

10.

Silverman, Bernard L., Christopher J. Barnes, Barbara N. Campaigne, & Douglas B. Muchmore. (2007). Inhaled insulin for controlling blood glucose in patients with diabetes. SHILAP Revista de lepidopterología. 5 indexed citations

11.

Pan, Alan X., Amparo de la Peña, Kwee Poo Yeo, et al.. (2007). Effects of smoking cessation, acute re‐exposure and nicotine replacement in smokers on AIR^® inhaled insulin pharmacokinetics and glucodynamics. British Journal of Clinical Pharmacology. 65(4). 480–487. 4 indexed citations

12.

Rosenstock, Julio, et al.. (2007). AIR^®Inhaled Insulin System: a novel insulin-delivery system for patients with diabetes. Expert Review of Medical Devices. 4(5). 683–692. 21 indexed citations

13.

Hayes, Risa P., et al.. (2007). Effect of Standard (Self-Directed) Training Versus Intensive Training for Lilly/Alkermes Human Insulin Inhalation Powder Delivery System on Patient-Reported Outcomes and Patient Evaluation of the System. Diabetes Technology & Therapeutics. 9(1). 89–98. 9 indexed citations

14.

Muchmore, Douglas B., et al.. (2006). Inhaled insulin delivery – where are we now?. Diabetes Obesity and Metabolism. 8(6). 634–642. 18 indexed citations

15.

Garg, Satish K., Julio Rosenstock, Bernard L. Silverman, et al.. (2006). Efficacy and safety of preprandial human insulin inhalation powder versus injectable insulin in patients with type 1 diabetes. Diabetologia. 49(5). 891–899. 55 indexed citations

16.

Rave, Klaus, Leszek Nosek, Lutz Heinemann, et al.. (2004). Inhaled micronized crystalline human insulin using a dry powder inhaler: dose‐response and time‐action profiles¹. Diabetic Medicine. 21(7). 763–768. 24 indexed citations

17.

Weinstein, Robert S., A. M. Parfitt, Robert Marcus, et al.. (2003). Effects of raloxifene, hormone replacement therapy, and placebo on bone turnover in postmenopausal women. Osteoporosis International. 14(10). 814–822. 57 indexed citations

18.

Dowsett, Mitch, N.J. Bundred, Andrea DeCensi, et al.. (2001). Effect of Raloxifene on Breast Cancer Cell Ki67 and Apoptosis. Cancer Epidemiology and Prevention Biomarkers. 10(9). 961–966. 4 indexed citations

19.

Muchmore, Douglas B., et al.. (1994). Self-monitoring of blood glucose in overweight type 2 diabetic patients. Acta Diabetologica. 31(4). 215–219. 88 indexed citations

20.

Muchmore, Douglas B., Stuart Little, & Christoph de Haën. (1981). A dual mechanism of action of ocytocin in rat epididymal fat cells.. Journal of Biological Chemistry. 256(1). 365–372. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact